LEVOFLOXACIN 250mg. IP + ORNIDAZOLE 500mg. IP

A combination of two antibacterial medicines that treat various infections of bacteria and parasites. A broad-spectrum, bactericidal antibiotic of the fluoroquinolone drug class that treats bacterial infections. (Podder & Sadiq, 2020) More active against gram-positive pathogens than ciprofloxacin. (Miriam Hurst, 2002) A therapeutic regimen in patients with uncomplicated skin and skin structure infections, and complicated urinary tract infections. (Miriam Hurst H. M., 2002) A promising therapeutic choice for gastrointestinal infections like acute diarrhea or dysentery, gynecology infections, and urinary infections. Exhibits good clinical and microbiological efficacy for use in lower respiratory tract infections that are caused by Streptococcus pneumoniae. (Guoying Cao, 2020) An attractive option for the treatment of at-risk patients with serious respiratory tract infections including community-acquired pneumonia and acute exacerbations of chronic bronchitis. (Rafael Cantón, 2006)